RE/MAX Holdings, Inc.
No SEC Form 4 filings for $RMAX in the last 30 days.
RE/MAX (NYSE:RMAX) reported Q2 CY2026 results that missed Wall Street expectations. Revenue fell 5.8% year on year to $68.51 million, and non-GAAP adjusted EPS was $0.32, down from $0.39 and 18.6% below consensus. Analysts expect revenue to rise 3.3% and full-year EPS to increase from $1.15 to $1.33.
RE/MAX Holdings (NYSE: RMAX) reported Q2 2026 revenue of $68.5M, down 5.8% year over year, and adjusted EBITDA of $22.9M, down 12.6%. GAAP net loss was $4.3M, or -$0.20 per diluted share. The company also disclosed a planned merger with The Real Brokerage, offering Real REMAX Group shares or $13.80 cash per RMAX share, expected to close in H2 2026.
RE/MAX Holdings, Inc. (RMAX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622438d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 RE/MAX HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Total Second Quarter Revenue of $68.5 Million, Adjusted EBITDA of $22.9 Million DENVER, August 6, 2026 Second Quarter 2026 Highlights (Compared to second quarter 2
Over the past 7 days, alphai's AI scored 4 news stories mentioning RMAX (RE/MAX Holdings, Inc.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 3 bearish.
Recent RMAX coverage spans earnings, mergers & acquisitions and sector analysis.
The miss on both revenue and adjusted EPS, plus margin compression, increases downside risk to near-term estimates and sentiment.
Near-term trading is likely driven by weak operating metrics plus deal overhang, with no further quarterly guidance during the pending transaction.
Near-term sentiment is likely pressured by weaker revenue and margin compression, partially offset by ongoing agent growth and cash balance.
Ahead of the earnings print, the key trade input is the gap between the prior quarter’s misses and the market’s expectation of flat year-over-year revenue.
Near-term downside risk for RMAX sentiment as deal-related franchise risks are highlighted, despite prior regulatory progress on HSR.
alphai scores every news story that mentions RMAX with an AI model for sentiment and relevance, and aggregates insider trades from RE/MAX Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
RE/MAX (NYSE:RMAX) reported Q2 CY2026 results that missed Wall Street expectations. Revenue fell 5.8% year on year to $68.51 million, and non-GAAP adjusted EPS was $0.32, down from $0.39 and 18.6% below consensus. Analysts expect revenue to rise 3.3% and full-year EPS to increase from $1.15 to $1.33.
4 min readRE/MAX Holdings (NYSE: RMAX) reported Q2 2026 revenue of $68.5M, down 5.8% year over year, and adjusted EBITDA of $22.9M, down 12.6%. GAAP net loss was $4.3M, or -$0.20 per diluted share. The company also disclosed a planned merger with The Real Brokerage, offering Real REMAX Group shares or $13.80 cash per RMAX share, expected to close in H2 2026.
6 min readRE/MAX Holdings, Inc. (RMAX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622438d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 RE/MAX HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Total Second Quarter Revenue of $68.5 Million, Adjusted EBITDA of $22.9 Million DENVER, August 6, 2026 Second Quarter 2026 Highlights (Compared to second quarter 2
6 min readRE/MAX (NYSE: RMAX) is set to report Q2 earnings Thursday. The company previously missed revenue and profit expectations, with Q1 revenue of $70.23 million, down 5.7% year on year, and it reported 149,192 agents, up 2.1%. Analysts expect Q2 revenue to be flat. RMAX shares are down 14.2% over the past month; average price target is $11.40 vs $9.73.
4 min readRE/MAX (RMAX) shares fell about 3% after analysts raised concerns about its acquisition by Real, saying the deal could weaken RE/MAX’s franchise model. Risks cited include competition for agents and customers, potential loss of franchisee equity and data control, especially for smaller franchises. The stock traded near $11.12.
4 min readRE/MAX (RMAX) shares rose after the DOJ granted early termination of the HSR waiting period for its proposed merger with The Real Brokerage, removing a key antitrust review hurdle. The deal still requires shareholder approvals. RMAX closed at $10.71, up 0.9% on the day.
3 min readReal’s SEC filing says the DOJ granted early termination of the antitrust waiting period for Real’s $880 million bid to buy RE/MAX. The FTC says early termination occurs only after both agencies complete review and plan no enforcement during the period. Shareholder approval is set for Aug. 14. Real shares rose about 4% after the filing.
4 min readA Q1 earnings “teardown” compares real-estate services stocks. Howard Hughes Holdings (HHH) reported $235.9M revenue (+18.4% YoY), beating analyst EPS; shares rose 14.2% to $72.53. RE/MAX (RMAX) revenue fell to $70.23M (-5.7%), missing expectations; shares down 4.6% to $10.55. The Real Brokerage (REAX) revenue $465.6M (+31.5%) missed; shares down 5% to $1.99. CBRE (CBRE) revenue $10.53B (+18.6%) beat; shares down 9.8% to $138.53.
6 min readStocks including Cushman & Wakefield (CWK, +2.7%) and RE/MAX (RMAX, +3%) rose after an Iran peace deal lowered Treasury yields, which can ease mortgage rates. The 10-year yield fell to 4.41% (lowest since mid-May) as oil dropped and inflation expectations repriced. The article links the move to rate-sensitive housing demand and notes RMAX is up 27.1% YTD but 16.7% below its 52-week high.
7 min readHalper Sadeh LLC, an investor rights law firm, is investigating RE/MAX Holdings, Inc. (RMAX), TopBuild Corp. (BLD), TruBridge, Inc. (TBRG), and QXO, Inc. (QXO) for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed transactions. The firm suggests that insiders may receive substantial financial benefits not available to ordinary shareholders and that some deal terms might limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options.
3 min read
